SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-17-002256
Filing Date
2017-03-29
Accepted
2017-03-29 16:40:36
Documents
5
Effectiveness Date
2017-03-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A rigl-20170329xdefa14a.htm DEFA14A 47274
2 GRAPHIC rigl20170329xdefa14a001.jpg GRAPHIC 58237
3 GRAPHIC rigl20170329xdefa14a002.gif GRAPHIC 63946
4 GRAPHIC rigl20170329xdefa14a003.jpg GRAPHIC 31183
5 GRAPHIC rigl20170329xdefa14a004.gif GRAPHIC 3293
  Complete submission text file 0001558370-17-002256.txt   264574
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-29889 | Film No.: 17722701
SIC: 2834 Pharmaceutical Preparations